allopregnane-3,20-diol has been researched along with alphaxalone in 1 studies
| Studies (allopregnane-3,20-diol) | Trials (allopregnane-3,20-diol) | Recent Studies (post-2010) (allopregnane-3,20-diol) | Studies (alphaxalone) | Trials (alphaxalone) | Recent Studies (post-2010) (alphaxalone) |
|---|---|---|---|---|---|
| 12 | 0 | 0 | 36 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadoni, C; Gee, KW | 1 |
1 other study(ies) available for allopregnane-3,20-diol and alphaxalone
| Article | Year |
|---|---|
Complex interactions between the steroid derivative RU 5135 and the GABAA-receptor complex.
Topics: Androstanes; Animals; Azasteroids; Binding, Competitive; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cerebral Cortex; Dose-Response Relationship, Drug; GABA-A Receptor Antagonists; gamma-Aminobutyric Acid; In Vitro Techniques; Male; Pregnanediol; Pregnanolone; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Stereoisomerism | 1992 |